Definitive Healthcare Corp. (NASDAQ:DH) Shares Sold by 272 Capital LP

272 Capital LP reduced its position in shares of Definitive Healthcare Corp. (NASDAQ:DH - Free Report) by 38.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 389,584 shares of the company's stock after selling 247,730 shares during the period. Definitive Healthcare comprises about 1.9% of 272 Capital LP's holdings, making the stock its 15th largest holding. 272 Capital LP owned about 0.34% of Definitive Healthcare worth $1,741,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the company. The Manufacturers Life Insurance Company increased its stake in Definitive Healthcare by 17.0% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 22,896 shares of the company's stock worth $125,000 after buying an additional 3,332 shares during the period. Principal Financial Group Inc. raised its stake in shares of Definitive Healthcare by 10.8% in the second quarter. Principal Financial Group Inc. now owns 39,856 shares of the company's stock valued at $218,000 after acquiring an additional 3,874 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in Definitive Healthcare by 31.4% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 21,292 shares of the company's stock valued at $116,000 after purchasing an additional 5,083 shares during the period. Glenmede Trust Co. NA grew its stake in Definitive Healthcare by 41.1% during the 3rd quarter. Glenmede Trust Co. NA now owns 18,423 shares of the company's stock worth $82,000 after purchasing an additional 5,362 shares in the last quarter. Finally, Valeo Financial Advisors LLC grew its stake in Definitive Healthcare by 11.8% during the 2nd quarter. Valeo Financial Advisors LLC now owns 59,080 shares of the company's stock worth $323,000 after purchasing an additional 6,230 shares in the last quarter. 98.67% of the stock is owned by institutional investors and hedge funds.

Definitive Healthcare Stock Performance

NASDAQ DH traded up $0.07 during trading hours on Friday, hitting $4.73. The company had a trading volume of 150,049 shares, compared to its average volume of 560,703. The business has a 50 day moving average of $4.35 and a 200-day moving average of $4.78. The company has a market cap of $546.41 million, a PE ratio of -1.53, a price-to-earnings-growth ratio of 3.49 and a beta of 1.33. Definitive Healthcare Corp. has a 1-year low of $3.19 and a 1-year high of $10.62. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.49 and a current ratio of 2.49.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the company. Barclays decreased their price objective on Definitive Healthcare from $6.00 to $4.00 and set an "equal weight" rating for the company in a research note on Wednesday, August 7th. Needham & Company LLC reiterated a "hold" rating on shares of Definitive Healthcare in a report on Friday, November 8th. Morgan Stanley dropped their price objective on shares of Definitive Healthcare from $9.00 to $5.00 and set an "equal weight" rating on the stock in a research report on Tuesday, August 6th. BTIG Research began coverage on shares of Definitive Healthcare in a research report on Tuesday, September 17th. They set a "buy" rating and a $7.00 price objective for the company. Finally, Robert W. Baird dropped their target price on Definitive Healthcare from $6.00 to $5.00 and set a "neutral" rating on the stock in a report on Wednesday, August 7th. One analyst has rated the stock with a sell rating, seven have given a hold rating and three have given a buy rating to the company. According to data from MarketBeat, Definitive Healthcare has an average rating of "Hold" and a consensus price target of $5.81.

Definitive Healthcare Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.